Amarjit Mishra is an expert in the field of pulmonological research and has been a skilled and dedicated scientist. He had previously worked as a research fellow at the NHLBI’s Cardiovascular and Pulmonary Branch at the National Institutes of Health in Maryland, USA. With more than 15 years of experience, Amarjit Mishra has been able to carry out innovative research, notably in relation to respiratory illnesses. His most recent studies have significantly improved our knowledge of allergic asthma. Amarjit Mishra an assistant professor at Auburn University, has been actively working on respiratory ailments, particularly in the area of inflammatory disorders.
The assistant professor Amarjit Mishra is renowned for his versatile expertise. He earned his PhD and master’s degrees in veterinary medicine in India. Amarjit Mishra went on to get a PhD (Doctor of Philosophy) from the Oklahoma Centre for Respiratory and Infectious Diseases (OCRID) in the Department of Physiological Sciences, Oklahoma State University in the United States, as a result of his intense interest and extensive expertise. Prior to joining Auburn University, Amarjit Mishra held the esteemed posts of Assistant Professor and Research and Postdoctoral Fellow at the National Institutes of Health’s Cardiovascular and Pulmonary Branch in Maryland, USA. He was a trailblazer in figuring out how dendritic cells affect allergic asthma.
Along with being a co-investigator in several of them, he has actively completed numerous funded studies. His most recent project which was funded by the National Institute of Health was titled “Th1/Th17 Immune Regulation in Severe Allergic Asthma”. The overall goal of the project was to identify the lung metabolite itaconate and study its specific role in Th1/Th17 immune response that could be employed as a target. The goal of the study was to determine the mechanism behind the inflammatory process in severe asthma. Prior to that, Amarjit Mishra, Assistant Professor at Auburn University had successfully bagged a grant by the National Heart, Lung and Blood Institute (NHLBI) of the National Institute of Health, USA. The NHLBI promotes the training and mentorship of young scientists and clinicians as well as the dissemination of research advancements to the general public. It also permits the conversion of fundamental findings into clinical practice. In collaboration with both public and private entities, including academic institutions, business, and other governmental agencies, it builds and sustains a strong, cooperative research infrastructure. The grant was sanctioned in 2018. Amarjit Mishra had investigated the functional significance of myeloid progenitor cells in obesity-related airway inflammation for this study. The study’s main goal was to pinpoint lineage-committed DC progenitors’ active roles in allergic asthma and obesity, as well as to outline the methods through which they control important adaptive immune responses. Its purpose was to increase our understanding of controlled hematopoiesis, progenitor proliferation, and differentiation. This project aimed to find novel therapeutic approaches for treating asthma in obese patients.
In addition to these initiatives, Amarjit Mishra served as co-principal investigator on a research funded by the National Institute on Aging. NIA was founded to do research aimed at enhancing older folks’ health and wellbeing. It carries out and promotes genetic, biological, behavioural, social, and economic studies on ageing and the difficulties and requirements of senior citizens. In order to increase the number of healthy, productive years of life, NIA is at the forefront of scientific research into the nature of healthy ageing. It also serves as the principal federal agency for research on dementias related to Alzheimer’s disease. In colleges, hospitals, and research institutes all around the United States and the globe, NIA supports innovative scientific projects. Additionally, it carries out research in its laboratories for science. it runs a robust communications and outreach programme to educate the public and the rest of the research community. The project granted to Amarjit Mishra of Auburn University was titled as “Longevity Genomics project”. The project aimed to study ADAMTS7 and function of lungs in aging. The study’s overall goal was to explore a translational approach and identify. The functions of lungs and of the candidate gene ADAMTS7, predicted from longevity genomics study in health and disease.
Amarjit Mishra also participated in other initiatives where he had modest involvement but they were nonetheless quite important. One such projects was led by Dr. Suryawanshi. This project was awarded by the National Eye Institute, a division under the National Institute of Health. The project focussed to elucidate the role of IL27 and macrophage immunometabolism in SK immunopathology. Another such project was undertaken by Dr. Greene and Amarjit Mishra were a part of the team. The Peer Reviewed Cancer Research Program (PRCRP) of the US Department of Defense provided funding for this investigation. In response to the demands of the general public and the US military, the CDMRP was established to promote innovative methods to biomedical research. This project focussed on studying Obesity-linked inflammation and colon cancer.
Through these projects, Amarjit Mishra had been able to set a feat in the field of science and technology. He is one of the top scientists who has committed his life to improving people’s quality of life.
